Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Maggiore

Showing results (91-100 of 100) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 100 results.
Plos One|September 5, 2018
Gastrointestinal presentation of Kawasaki disease: A red flag for severe disease?Marianna Fabi, Elena Corinaldesi, Luca Pierantoni, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 21, 2024
Effectiveness and Safety of Glecaprevir/Pibrentasvir in Italian Children and Adolescents With Chronic Hepatitis C: A Real-Word, Multicenter StudyMariangela Stinco, Chiara Rubino, Elisa Bartolini, et al.
Clinical Immunology (Orlando, Fla.)|February 8, 2011
Clinical heterogeneity and diagnostic delay of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndromeCinzia Mazza, Fabio Buzi, Federica Ortolani, et al.
The Lancet. Gastroenterology & Hepatology|April 26, 2024
Efficacy and safety of odevixibat in patients with Alagille syndrome (ASSERT): a phase 3, double-blind, randomised, placebo-controlled trialNadia Ovchinsky, Madeleine Aumar, Alastair Baker, et al.
American Journal of Human Genetics|April 9, 2022
Progressive liver, kidney, and heart degeneration in children and adults affected by TULP3 mutationsJohn Devane, Elisabeth Ott, Eric G Olinger, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|October 24, 2021
Diagnostic approach to neonatal and infantile cholestasis: A position paper by the SIGENP liver disease working groupGiusy Ranucci, Claudia Della Corte, Daniele Alberti, et al.
Frontiers in Immunology|July 20, 2023
The Italian data on SARS-CoV-2 infection in transplanted patients support an organ specific immune response in liver recipientsMaria Rendina, Michele Barone, Chiara Lillo, et al.
JHEP Reports : Innovation in Hepatology|April 25, 2025
Recurrence of autoimmune hepatitis cholestatic variant syndromes after liver transplantation affects graft and patient survivalVincenzo Ronca, Alessandro Parente, Ellina Lytvyak, et al.
Journal of Hepatology|February 10, 2022
Risk factors and outcomes associated with recurrent autoimmune hepatitis following liver transplantationAldo J Montano-Loza, Vincenzo Ronca, Maryam Ebadi, et al.
BMJ Open|July 27, 2023
Prevalence, management and efficacy of treatment in portal vein obstruction after paediatric liver transplantation: protocol of the retrospective international multicentre PORTAL registryBader A Alfares, Hubert P J van der Doef, Barbara E Wildhaber, et al.
Pageof 10

Showing results (91-100 of 100) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 100 results.
Plos One|September 5, 2018
Gastrointestinal presentation of Kawasaki disease: A red flag for severe disease?Marianna Fabi, Elena Corinaldesi, Luca Pierantoni, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 21, 2024
Effectiveness and Safety of Glecaprevir/Pibrentasvir in Italian Children and Adolescents With Chronic Hepatitis C: A Real-Word, Multicenter StudyMariangela Stinco, Chiara Rubino, Elisa Bartolini, et al.
Clinical Immunology (Orlando, Fla.)|February 8, 2011
Clinical heterogeneity and diagnostic delay of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndromeCinzia Mazza, Fabio Buzi, Federica Ortolani, et al.
The Lancet. Gastroenterology & Hepatology|April 26, 2024
Efficacy and safety of odevixibat in patients with Alagille syndrome (ASSERT): a phase 3, double-blind, randomised, placebo-controlled trialNadia Ovchinsky, Madeleine Aumar, Alastair Baker, et al.
American Journal of Human Genetics|April 9, 2022
Progressive liver, kidney, and heart degeneration in children and adults affected by TULP3 mutationsJohn Devane, Elisabeth Ott, Eric G Olinger, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|October 24, 2021
Diagnostic approach to neonatal and infantile cholestasis: A position paper by the SIGENP liver disease working groupGiusy Ranucci, Claudia Della Corte, Daniele Alberti, et al.
Frontiers in Immunology|July 20, 2023
The Italian data on SARS-CoV-2 infection in transplanted patients support an organ specific immune response in liver recipientsMaria Rendina, Michele Barone, Chiara Lillo, et al.
JHEP Reports : Innovation in Hepatology|April 25, 2025
Recurrence of autoimmune hepatitis cholestatic variant syndromes after liver transplantation affects graft and patient survivalVincenzo Ronca, Alessandro Parente, Ellina Lytvyak, et al.
Journal of Hepatology|February 10, 2022
Risk factors and outcomes associated with recurrent autoimmune hepatitis following liver transplantationAldo J Montano-Loza, Vincenzo Ronca, Maryam Ebadi, et al.
BMJ Open|July 27, 2023
Prevalence, management and efficacy of treatment in portal vein obstruction after paediatric liver transplantation: protocol of the retrospective international multicentre PORTAL registryBader A Alfares, Hubert P J van der Doef, Barbara E Wildhaber, et al.
Pageof 10